ANGPT2 and hepatocellular carcinoma: The cumulative incidences of HCC recurrence at two and four years were 45.2% and 78.5% in the Ang2 ≥ 446 pg/mL group and 26.3% and 38.6% in the Ang2 < 446 pg/mL group, respectively.